ストックスクリーナーアプリを入手
2.14
1.77%
0.04
前日終値:
$2.10
開ける：
$2.13
24時間の取引高:
911.72K
Relative Volume:
2.44
時価総額：
$91.99M
収益：
$51.13M
当期純損益:
$-93.80M
株価収益率:
-0.9596
EPS:
-2.23
ネットキャッシュフロー:
$-129.10M
1週間 パフォーマンス:
+29.52%
1か月 パフォーマンス:
+13.68%
6か月 パフォーマンス:
+61.90%
1年 パフォーマンス:
-28.04%
1日の値動き範囲:
$2.10
$2.185
1週間の範囲:
$2.02
$2.30
52週間の値動き範囲:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
名前
Repare Therapeutics Inc
セクター
電話
(857) 412-7018
住所
7171 FREDERICK BANTING, SAINT-LAURENT, QC
RPTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
2.14 | 90.27M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.06 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.11 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
922.65 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.09 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-06-09 | アップグレード | Stifel | Hold → Buy |
| 2023-02-03 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | 開始されました | CapitalOne | Overweight |
| 2022-04-12 | ダウングレード | Stifel | Buy → Hold |
| 2022-03-17 | 再開されました | Goldman | Buy |
| 2021-09-23 | 開始されました | Stifel | Buy |
| 2021-09-13 | 開始されました | H.C. Wainwright | Buy |
| 2021-06-28 | 開始されました | Guggenheim | Buy |
| 2021-03-01 | 開始されました | Berenberg | Buy |
| 2020-10-28 | 開始されました | Northland Capital | Outperform |
| 2020-07-14 | 開始されました | Cowen | Outperform |
| 2020-07-14 | 開始されました | Goldman | Neutral |
| 2020-07-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Repare Therapeutics Inc (RPTX) 最新ニュース
Repare signs support agreements with key shareholders for Xenotherapeutics deal - MarketScreener
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - FinancialContent
Why hedge funds are buying Repare Therapeutics Inc. stockJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Repare Therapeutics Reports Positive Q3 2025 Results - TipRanks
Can Repare Therapeutics Inc. stock rebound after recent weaknessQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Why Repare Therapeutics Inc. stock could rally in 2025Index Update & Risk Controlled Swing Trade Alerts - newser.com
Smart tools for monitoring Repare Therapeutics Inc.’s price action2025 Momentum Check & Smart Money Movement Tracker - newser.com
TD Cowen Downgrades Repare Therapeutics (NASDAQ:RPTX) to Hold - MarketBeat
Risk adjusted return profile for Repare Therapeutics Inc. analyzedRisk Management & Technical Pattern Alert System - newser.com
Applying chart zones and confluence areas to Repare Therapeutics Inc.July 2025 Snapshot & Daily Entry Point Alerts - newser.com
Repare Therapeutics Inc. (RPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Candlestick signals on Repare Therapeutics Inc. stock todayJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX) - MarketBeat
Repare Therapeutics Announces Acquisition by XenoTherapeutics - MSN
Real time scanner hits for Repare Therapeutics Inc. explainedJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An - GlobeNewswire
Repare Therapeutics Gains Attention Amid Acquisition Buzz - StocksToTrade
Cambridge-Montreal biotech Repare Therapeutics to be acquired by XenoTherapeutics - The Business Journals
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025 - ts2.tech
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga
Repare Therapeutics Unveils Phase 1 LIONS Trial Data - MSN
[8-K] Repare Therapeutics Inc. Reports Material Event | RPTX SEC FilingForm 8-K - Stock Titan
Repare Therapeutics (RPTX) on Acquisition Path: Explained - timothysykes.com
TD Cowen Downgrades Repare Therapeutics to Hold From Buy - MarketScreener
Repare Therapeutics stock rating downgraded to Hold by TD Cowen after acquisition news - Investing.com
Repare +30%, Nuvalent +9% Lead After-Hours Biotech Gains - Nasdaq
Repare Therapeutics to be Acquired by XenoTherapeutics - citybiz
Repare Therapeutics (NASDAQ:RPTX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move - MSN
Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 - MSN
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders - The AI Journal
How Repare Therapeutics Inc. stock compares to industry benchmarksWeekly Risk Report & High Yield Equity Trading Tips - newser.com
Why Repare Therapeutics Inc. stock remains resilientRate Cut & Daily Profit Maximizing Trade Tips - newser.com
Repare Therapeutics Inc (RPTX) 財務データ
収益
当期純利益
現金流量
EPS
Repare Therapeutics Inc (RPTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER |
Mar 12 '25 |
Sale |
1.14 |
5,611 |
6,397 |
80,297 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER |
Mar 12 '25 |
Sale |
1.14 |
6,884 |
7,848 |
54,786 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO |
Mar 12 '25 |
Sale |
1.14 |
21,179 |
24,144 |
124,394 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):